Clinical Trial: A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07268040) titled 'A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors' on Nov. 24.

Brief Summary: This study aims to evaluate the safety, tolerability and efficacy of SHR-7787 in combination with other anti-tumor drugs in patients with malignant solid tumors.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Malignant Solid Tumors

Intervention: DRUG: SHR-7787 Injection

SHR-7787 Injection.

DRUG: SHR-1316 Injection

SHR-1316 Injection.

DRUG: SHR-4849 Injection

SHR-4849 Injection.

DRUG: Etoposide injection

Etoposide Injection.

DRUG: Carboplatin injection

Carboplatin Inj...